What If: We Become Superhuman?

26 de junio de 2016 9:30

Pharmacology, genetic engineering and robotics promise powerful treatments that go beyond therapy. What if human enhancements become essential to compete for top grades and top jobs?

Explore the possible, plausible and probable impacts of human enhancement.

This session was developed in partnership with TIME.

Simultaneous interpretation in English, Mandarin Chinese and Japanese

As this session is televised, please arrive 15 minutes early. The doors will be closed at the scheduled time. This session is webcast live.

Oradores:

Nita Farahany

Robinson O. Everett Professor of Law and Philosophy; Director, Duke Science and Society, Duke University

Girish P. Ramachandran

President, Growth Markets, Tata Consultancy Services

Mart Saarma

Vice-President, European Research Council

Nina Tandon

President and Chief Executive Officer, EpiBone

Matt Vella

Business Editor, TIME